xgeva
(denosumab)Amgen Inc
Usage: Xgeva is indicated for the prevention of skeletal-related events in patients with multiple myeloma and bone metastases from solid tumors. It treats giant cell tumor of bone that is unresectable or poses severe surgical risks, and it addresses hypercalcemia of malignancy that is refractory to bisphosphonate therapy.